Purple Biotech Ltd.

Regulatory Filings • May 5, 2020

_________ false

����� ����� ��"�	2 352
KITOV PHARMA LTD
Corporation no: 520031238	10994
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	04/05/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-044043	Time of broadcast: 22:27 22:22:58

---

Immediate report on other matterDon't use this form if there is more adequate one

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM D Notice of Exempt Offering of Securities KITOV PHARMA LTD. ����� ������ ������ �� ������ ���� "��" ���� ���"� �� ����� ��� ����� ���� ������ ��"� �� ����� ��� ������ ����"� ���� �� �� ���� ������ ������ ���� ����� ������� �� �����. ��� �� ���� ����� ���� �� ����� ����� ����� ������ ������ ���� �� ������ ������ ���� �� �����, ��� ����� ����� �� ����� ������ ���� ��� ����� �� ���� �����, �� �� ����, ����� �� ����� ���� ����� ����� ���� ����� ���� ������ �� ���� �������� ����� ����� ������ ��� ��� ����� �� ���� �����
Attached file ea121351-d_kitovEDGAR1_isa.pdf

The submission by the Company to the Israel Securities Authority and the Tel Aviv Stock Exchange of a copy of a Form D originally submitted by the Company to the United States Securities Exchange Commission for the purposes of notifying the United States Securities Exchange Commission, as well for purposes of notifying the applicable State(s) of solicitation, of an exempt offering of securities in the United States of America and within such applicable State(s) of solicitation, should not be deemed an admission by the Company that such submission is required of the Company under the Securities Law 5728-1968 and the Securities Regulations (Periodic and Immediate Reports of Foreign Corporation) 5761-2000, nor an admission by the Company that this submission is necessarily being delivered pursuant to the aforesaid laws and regulations.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2020-02-039606
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 22/04/2020
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: info@kitovpharma.com   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company: ABZ Law Office
Address: Yad Harutzim 15 , Jerusalem 9342152 Telephone: 079-5722070 Facsimile: 079-5722206 E-mail: abz@abz-law.com 1
Israel